📰 Johan Gil News
Johan Gil News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Johan Gil. Real-time updates on events, politics, business and more.
November 21, 2023
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) ("InDex Pharmaceuticals") today announces that an independent DMC has completed the planned dose...
November 21, 2023
STOCKHOLM, Nov. 21, 2023 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) ("InDex Pharmaceuticals")...
November 21, 2023
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) ("InDex Pharmaceuticals") today announces that an independent DMC has completed the planned dose...
October 20, 2023
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that a new method of use patent for the drug candidate cobitolimod has been granted by...
October 11, 2023
STOCKHOLM, Oct. 11, 2023 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that 30% of...
October 5, 2023
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) will attend the United European Gastroenterology Week (UEGW), one of the worlds leading...
August 22, 2023
STOCKHOLM, Aug. 22, 2023 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that the...
August 2, 2023
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that a new formulation patent for the drug candidate cobitolimod has been granted by...
May 31, 2023
STOCKHOLM, May 31, 2023 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) ("InDex") today announced that a license agreement has been signed with Viatris Pharmaceutical Japan Inc. ("Viatris
May 31, 2023
/PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) will hold an investor call in light of todays press release announcing the companys license agreement....